US$ 27.44
history of glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The transformative breakthroughs in GLP-1
Description
The use of DPP-4is as a comparator provided a highly comparable control group, particularly as both drugs were used in the setting of sole add-on medication to metformin, and both drugs have similar priority in the management of T2D

[DOI] [PubMed] [Google Scholar] 140.Pawaskar M., Bilir S.P., Kowal S., Gonzalez C., Rajpathak S., Davies G

Dixit AA, Bateman BT, Hawn MT, Odden MC, Sun EC

Pancreatic safety of incretin-based drugs-FDA and EMA assessment

The prevalence of these conditions is increasing at an alarming rate
